Literature DB >> 33593678

Considering rationales for use in defining subgroups for the treatment of stimulant use disorder.

Olivia Brooks1, Paxton Bach2, Kanna Hayashi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33593678      PMCID： PMC8026728          DOI： 10.1016/j.drugalcdep.2021.108572

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN： 0376-8716            Impact factor:   4.492


× No keyword cloud information.
  12 in total

1.  Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Authors:  Grant N Colfax; Glenn-Milo Santos; Moupali Das; Deirdre McDermott Santos; Tim Matheson; James Gasper; Steve Shoptaw; Eric Vittinghoff
Journal:  Arch Gen Psychiatry       Date:  2011-11

Review 2.  Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.

Authors:  Brian Chan; Michele Freeman; Karli Kondo; Chelsea Ayers; Jessica Montgomery; Robin Paynter; Devan Kansagara
Journal:  Addiction       Date:  2019-09-12       Impact factor: 6.526

3.  Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?

Authors:  Laura Brandt; Thomas Chao; Sandra D Comer; Frances R Levin
Journal:  Addiction       Date:  2020-09-28       Impact factor: 6.526

4.  Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment.

Authors:  Heather Palis; Scott Harrison; Scott MacDonald; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Drug Alcohol Rev       Date:  2020-06-25

5.  To house or not to house: the effects of providing housing to homeless substance abusers in treatment.

Authors:  Jesse B Milby; Joseph E Schumacher; Dennis Wallace; Michelle J Freedman; Rudy E Vuchinich
Journal:  Am J Public Health       Date:  2005-07       Impact factor: 9.308

6.  Understanding concurrent stimulant use among people on methadone: A qualitative study.

Authors:  Ryan McNeil; Nitsaha Puri; Jade Boyd; Samara Mayer; Kanna Hayashi; Will Small
Journal:  Drug Alcohol Rev       Date:  2020-03

Review 7.  Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups.

Authors:  Edna Soares; Frederico C Pereira
Journal:  Expert Opin Pharmacother       Date:  2019-10-31       Impact factor: 3.889

8.  Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

Authors:  John Grabowski; Howard Rhoades; Angela Stotts; Katherine Cowan; Charles Kopecky; Anne Dougherty; F Gerard Moeller; Sohela Hassan; Joy Schmitz
Journal:  Neuropsychopharmacology       Date:  2004-05       Impact factor: 7.853

9.  Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.

Authors:  Anna Palmer; Nick Scott; Paul Dietze; Peter Higgs
Journal:  Harm Reduct J       Date:  2020-02-27

10.  Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.

Authors:  Phillip O Coffin; Glenn-Milo Santos; Jaclyn Hern; Eric Vittinghoff; John E Walker; Tim Matheson; Deirdre Santos; Grant Colfax; Steven L Batki
Journal:  JAMA Psychiatry       Date:  2020-03-01       Impact factor: 21.596
View more
  2 in total

1.  Crystal methamphetamine use subgroups and associated addiction care access and overdose risk in a Canadian urban setting.

Authors:  Olivia Brooks; Paxton Bach; Huiru Dong; M-J Milloy; Nadia Fairbairn; Thomas Kerr; Kanna Hayashi
Journal:  Drug Alcohol Depend       Date:  2022-01-11       Impact factor: 4.492

2.  Medical Detoxification for Nonopioid Substances is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment.

Authors:  Laura MacKinnon; JinCheol Choi; Mary Clare Kennedy; Rupinder Brar; M-J Milloy; Kanna Hayashi; Maria Eugenia Socías
Journal:  J Addict Med       Date:  2022-03-01       Impact factor: 4.647
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.